Letters by company
Par Technology CORP
11 letters discussing PAR. Everything written about it on this site is on its ticker page.
- Greenhaven Road Capital Q1 2024 Greenhaven Road Capital argues that PAR Technology’s restaurant-software expansion, Cellebrite’s digital-evidence tools, KKR’s asset-gathering model and Burford’s litigation portfolio reward patient ownership. The fund exited Sphere and added Louisiana-Pacific and Alta Group, citing their business transitions, durable service economics and capital-allocation potential. first quarter — PAR $804MANY $18MBUR $946MCLBT $2.9B
- Greenhaven Road Capital Q1 2022 Greenhaven Road Capital added to PAR Technology and Teladoc Health while defending KKR, Elastic, and Digital Turbine as businesses whose fundamentals remain intact despite multiple compression. The fund also established a cannabis-stock basket, arguing that federal restrictions and fragmented state licensing create mispriced, cash-generative U.S. operators. first quarter -26.5% APPS $1.3BESTC $8.9BKKR $96BPAR $804M
- Greenhaven Road Capital Q1 2021 Greenhaven Road added to PAR Technology after its Punchh acquisition, retained conviction in Elastic’s customer monetization and KKR’s permanent-capital model, and saw RCI Hospitality become a top holding. The fund sold Twitter after rapid appreciation and is building SPAC capabilities through warrants, a specialist-manager seed investment and a Special Opportunities Fund. first quarter +14.0% APPS $1.3BESTC $8.9BKKR $96BPAR $804M
- Greenhaven Road Capital Q1 2019 Greenhaven Road Capital built positions in PAR Technology and Digital Turbine, arguing that overlooked software and app-installation businesses can monetize recurring revenue more effectively under improved management and distribution. The fund added to SharpSpring, replaced Fiat Chrysler shares with long-dated options, and backed Chicken Soup for the Soul Entertainment’s Crackle venture. Q1 2019 — APPS $1.3BPAR $804MBOX $4.6BCSSE delisted
- Royce Investment Partners Royce Small-Cap Fund Manager Commentary Royce Small-Cap Fund favored semiconductor and infrastructure suppliers including Element Solutions, Onto Innovation, MKS, Ultra Clean Holdings, and Arcosa. It exited PAR Technology, ADMA Biologics, Kyndryl Holdings, and TransMedics after deteriorating theses, while adding to Maximus on what it viewed as an attractive valuation. year-to-date period ended 6/30/26 +23.8% ACA $7.1BADMA $2.3BESI $8.5BKD $2.8B
- Royce Investment Partners Royce Micro-Cap Fund Manager Commentary Royce Micro-Cap Fund emphasized AI-infrastructure suppliers Ichor Holdings, Ultra Clean Holdings, Applied Optoelectronics, Vishay Precision Group, and Cohu. The managers exited PAR Technology and Forward Air, added to PowerFleet and EVI Industries, and began reallocating technology winners toward undervalued staffing, software, agriculture, commercial-vehicle, and medical-technology opportunities. first half of 2026 +45.4% AAOI $11BAIOT $409MAORT $1.4BCOHU $2.6B
- Greenhaven Road Capital Q4 2025 Greenhaven Road Capital groups Lifecore and Vistry as “Bamboo Trees,” where operational transformations and capacity or partnership-model progress have yet to be reflected in valuations. It argues that fears around AI disruption, litigation, fundraising and credit are mispriced at PAR, Cellebrite, Burford and KKR, while Hagerty benefits from State Farm onboarding and marketplace growth. Q4 2025 -2.0% BUR $946MCLBT $2.9BHGTY $4.6BKKR-P-D
- Greenhaven Road Capital Q1 2025 Kingsway Financial is presented as a new purchase built around a Search Xcelerator that backs operators acquiring small, asset-light businesses, with tax losses and experienced advisers adding optionality. Greenhaven Road added to Lifecore, Vistry and Hagerty during tariff-driven weakness, while arguing that its core holdings retain limited direct trade exposure. Q1 2025 -12.0% KFS BUR $946MCLBT $2.9BKKR $96B
- Greenhaven Road Capital Q1 2023 Greenhaven Road Capital argues that PAR Technology, KKR, Cellebrite and API Group have durable earnings foundations through low churn, strong balance sheets and non-discretionary demand. It adds Burford Capital, while treating Lifecore and Barnes & Noble Education as smaller special situations tied to asset sales and operational transitions. first quarter +17.0% BUR $946MAPG $18BBNED $415MCLBT $2.9B
- Greenhaven Road Capital Q1 2020 Greenhaven Road Capital retained SharpSpring, Digital Turbine and PAR Technology despite pandemic-driven pressure, arguing that their balance sheets, management teams and competitive positions could strengthen through the disruption. The portfolio added smaller positions in Uber, Roku, Pinterest and Carvana while emphasizing liquidity, durable business models and selective opportunities created by market panic. Q1 — APPS $1.3BCSSE delistedKKR $96BKLR delisted
- Greenhaven Road Capital Main Fund Q2 Greenhaven Road Capital is reducing concentration and adding catalyst-driven positions while retaining its emphasis on differentiated research. It argues that Burford’s protein litigation, Hagerty’s insurer partnerships, Cellebrite’s Genesis rollout, Lifecore’s capacity sales and Kingsway’s search-model buildout can close gaps between market expectations and business value. Q2 2026 +11.0% BUR $946MCLBT $2.9BHGTY $4.6BANAB $1.7B
